Storage in dose administration aids doesn't affect warfarin

December 4, 2017

(HealthDay)—The chemical stability of warfarin sodium tablets is not affected by repackaging into dose administration aids (DAAs), according to a study published online Nov. 16 in the Journal of Pharmacy Practice and Research.

Caynan Mendes Rugno, B.Pharm., from RMIT University in Bundoora, Australia, and colleagues examined the of sodium tablets stored in DAAs and original packaging over an eight-week period. Tablets were removed from the original packaging and repackaged into DAAs; DAAs and original packages were stored at controlled room temperature (25 degrees Celsius; 60 percent relative humidity [RH]), accelerated (40 degrees Celsius/75 percent RH), and uncontrolled room temperature conditions (19 to 21 degrees Celsius/38 to 50 percent RH). A validated high-performance liquid chromatography method was used to assess the chemical stability.

The researchers found that at eight weeks there was no significant change in warfarin content. When stored at accelerated and controlled room temperature conditions there was a significant increase in hardness. At eight weeks, hardness of tablets stored in original packaging was comparable to that of those stored in DAAs. Compared with baseline, there was a significant difference in the dissolution profile of tablets stored in original containers at accelerated conditions for eight weeks.

"Repackaging of warfarin sodium tablets into DAAs does not affect the ," the authors write. "However, tablets should be stored in a cool, dry place to minimize the effects on physical properties."

Explore further: Bevacizumab safe, stable for multiple dosing from single vial

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Bevacizumab safe, stable for multiple dosing from single vial

July 24, 2015
(HealthDay)—Bevacizumab is safe and stable when stored at 4 degrees Celsius, even with multiple dosing from a single vial, according to a study published in the July issue of Clinical & Experimental Ophthalmology.

More diabetes-associated, non-associated autoantibodies in T1D

September 6, 2016
(HealthDay)—Patients with type 1 diabetes have more diabetes-associated autoantibodies (DAAs) and non-DAAs than patients with type 2 diabetes, according to a study published online Aug. 29 in Diabetes Care.

One-third of patients don't retain important warfarin info

August 15, 2016
(HealthDay)—Just over two-thirds of patients retain an "acceptable" amount of key information following warfarin counseling, according to a small study published online Aug. 6 in the Journal of Pharmacy Practice and Research.

Stability of fragrance patch test preparations examined

July 26, 2012
(HealthDay) -- Concentrations of several fragrance allergens applied to test chambers well in advance of patient testing may be reduced by 20 percent or more within hours when stored at room temperature, according to a study ...

Warfarin, rivaroxaban similarly safe, effective

September 12, 2017
(HealthDay)—For cases of mild atrial fibrillation (AF)-related acute ischemic stroke, rivaroxaban and warfarin are similarly safe and effective at preventing recurrent stroke, according to a study published online Sept. ...

HBV reactivation is concern with DAA Tx in HBV-HCV coinfection

April 25, 2017
(HealthDay)—Hepatitis B virus (HBV) reactivation (HBV-R) is a safety concern for patients with HBV and hepatitis C virus (HCV) coinfection receiving direct-acting antiviral agents (DAAs), according to a study published ...

Recommended for you

Heart researchers develop a new, promising imaging technique for cardiac arrhythmias

February 22, 2018
Every five minutes in Germany alone, a person dies of sudden cardiac arrest or fibrillation, the most common cause of death worldwide. This is partly due to the fact that doctors still do not fully understand exactly what ...

Scientists use color-coded tags to discover how heart cells develop

February 22, 2018
UCLA researchers used fluorescent colored proteins to trace how cardiomyocytes—cells in heart muscle that enable it to pump blood—are produced in mouse embryos. The findings could eventually lead to methods for regenerating ...

Beetroot juice supplements may help certain heart failure patients

February 22, 2018
Beetroot juice supplements may help enhance exercise capacity in patients with heart failure, according to a new proof-of-concept study. Exercise capacity is a key factor linked to these patients' quality of life and even ...

'Beetroot pill' could help save patients from kidney failure after heart X-ray

February 22, 2018
Beetroot may reduce the risk of kidney failure in patients having a heart x-ray, according to research led by Queen Mary University of London.

Women once considered low risk for heart disease show evidence of previous heart attack scars

February 20, 2018
Women who complain about chest pain often are reassured by their doctors that there is no reason to worry because their angiograms show that the women don't have blockages in the major heart arteries, a primary cause of heart ...

Can your cardiac device be hacked?

February 20, 2018
Medical devices, including cardiovascular implantable electronic devices could be at risk for hacking. In a paper publishing online today in the Journal of the American College of Cardiology, the American College of Cardiology's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.